Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sickle cell disease in Germany: Results from a national registry.
Kunz JB, Lobitz S, Grosse R, Oevermann L, Hakimeh D, Jarisch A, Cario H, Beier R, Schenk D, Schneider D, Groß-Wieltsch U, Prokop A, Heine S, Khurana C, Erlacher M, Dürken M, Linke C, Frühwald M, Corbacioglu S, Claviez A, Metzler M, Ebinger M, Full H, Wiesel T, Eberl W, Reinhard H, Tagliaferri L, Allard P, Karapanagiotou-Schenkel I, Rother LM, Beck D, Le Cornet L, Kulozik AE; German Sickle Cell Disease Registry. Kunz JB, et al. Among authors: corbacioglu s. Pediatr Blood Cancer. 2020 Apr;67(4):e28130. doi: 10.1002/pbc.28130. Epub 2019 Dec 22. Pediatr Blood Cancer. 2020. PMID: 31867835
Sorafenib and cisplatin/doxorubicin (PLADO) in pediatric hepatocellular carcinoma.
Schmid I, Häberle B, Albert MH, Corbacioglu S, Fröhlich B, Graf N, Kammer B, Kontny U, Leuschner I, Scheel-Walter HG, Scheurlen W, Werner S, Wiesel T, von Schweinitz D. Schmid I, et al. Among authors: corbacioglu s. Pediatr Blood Cancer. 2012 Apr;58(4):539-44. doi: 10.1002/pbc.23295. Epub 2011 Sep 15. Pediatr Blood Cancer. 2012. PMID: 21922643 Clinical Trial.
The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis.
Hartz B, Marsh R, Rao K, Henter JI, Jordan M, Filipovich L, Bader P, Beier R, Burkhardt B, Meisel R, Schulz A, Winkler B, Albert MH, Greil J, Karasu G, Woessmann W, Corbacioglu S, Gruhn B, Holter W, Kühl JS, Lang P, Seidel MG, Veys P, Löfstedt A, Ammann S, Ehl S, Janka G, Müller I, Lehmberg K. Hartz B, et al. Among authors: corbacioglu s. Blood. 2016 Jun 23;127(25):3281-90. doi: 10.1182/blood-2015-12-684498. Epub 2016 Apr 20. Blood. 2016. PMID: 27099148 Free PMC article.
Haploidentical stem cell transplantation with CD3+-/CD19+- depleted peripheral stem cells for patients with advanced stage sickle cell disease and no alternative donor: results of a pilot study.
Foell J, Pfirstinger B, Rehe K, Wolff D, Holler E, Corbacioglu S. Foell J, et al. Among authors: corbacioglu s. Bone Marrow Transplant. 2017 Jun;52(6):938-940. doi: 10.1038/bmt.2017.49. Epub 2017 Apr 24. Bone Marrow Transplant. 2017. PMID: 28436975 Clinical Trial. No abstract available.
Clinical characteristics and outcome of 60 pediatric patients with malignant melanoma registered with the German Pediatric Rare Tumor Registry (STEP).
Offenmueller S, Leiter U, Bernbeck B, Garbe C, Eigentler T, Borkhardt A, Classen CF, Corbacioglu S, Dirksen U, Ebetsberger-Dachs G, Heinzerling L, Jorch N, Kuhlen M, Lawlor J, Niggli F, Streiter M, Schneider DT, Brecht I. Offenmueller S, et al. Among authors: corbacioglu s. Klin Padiatr. 2017 Nov;229(6):322-328. doi: 10.1055/s-0043-118662. Epub 2017 Oct 10. Klin Padiatr. 2017. PMID: 29017184 English.
Haploidentical CD3 or α/β T-cell depleted HSCT in advanced stage sickle cell disease.
Foell J, Schulte JH, Pfirstinger B, Troeger A, Wolff D, Edinger M, Hofmann P, Aslanidis C, Lang P, Holler E, Eggert A, Corbacioglu S. Foell J, et al. Among authors: corbacioglu s. Bone Marrow Transplant. 2019 Nov;54(11):1859-1867. doi: 10.1038/s41409-019-0550-0. Epub 2019 May 14. Bone Marrow Transplant. 2019. PMID: 31089288
205 results